Xavier Thomas
Impact in
- Hematology top 0.05%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
-
- Acute Lymphoblastic Leukemia research
Papers in
- Hematology 295
- Acute Myeloid Leukemia Research 250
- Hematopoietic Stem Cell Transplantation 38
- Chronic Myeloid Leukemia Treatments 16
-
- Acute Lymphoblastic Leukemia research 132
- Co-authors
- Hervé Dombret (107 shared papers)Emmanuel Raffoux (55 shared papers)Françoise Huguet (51 shared papers)Denis M. Fiere (53 shared papers)Claude Preudhomme (45 shared papers)Véronique Lhéritier (37 shared papers)Pierre Fenaux (45 shared papers)Mauricette Michallet (88 shared papers)
- Journals
- Blood (147 papers)Leukemia (39 papers)Journal of Clinical Oncology (26 papers)Leukemia Research (21 papers)Haematologica (17 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Xavier Thomas
498 papers receiving 22k citations
Xavier Thomas's Hit Papers
Peers
Comparison fields: 5 of 127
- Hematology 10.9k
- Public Health, Environmental and Occupational Health 6.3k
- Oncology 1.8k
- Molecular Biology 3k
- Genetics 288
Countries citing papers authored by Xavier Thomas
This map shows the geographic impact of Xavier Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Thomas more than expected).
Fields of papers citing papers by Xavier Thomas
This network shows the impact of papers produced by Xavier Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Thomas. The network helps show where Xavier Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Xavier Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 509 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia Hit paper breakdown → | 2017 | 1709 |
| 2 | Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia Hit paper breakdown → | 2012 | 986 |
| 3 | Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study Hit paper breakdown → | 2012 | 845 |
| 4 | Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials Hit paper breakdown → | 2003 | 508 |
| 5 | Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study Hit paper breakdown → | 2009 | 489 |
| 6 | 2004 | 459 | |
| 7 | 2002 | 438 | |
| 8 | 2016 | 380 | |
| 9 | 2013 | 312 | |
| 10 | 2006 | 305 | |
| 11 | Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia Hit paper breakdown → | 2015 | 303 |
| 12 | Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial Hit paper breakdown → | 2018 | 290 |
| 13 | Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia Hit paper breakdown → | 2016 | 285 |
| 14 | Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia Hit paper breakdown → | 2014 | 284 |
| 15 | 2006 | 276 | |
| 16 | 2016 | 259 | |
| 17 | 2017 | 253 | |
| 18 | 2006 | 252 | |
| 19 | 2015 | 221 | |
| 20 | 2007 | 215 |
About Xavier Thomas
Xavier Thomas is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Molecular Biology, Oncology and Infectious Diseases, having authored 509 papers that have together received 22.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (250 papers), Acute Lymphoblastic Leukemia research (132 papers), Retinoids in leukemia and cellular processes (50 papers), Hematopoietic Stem Cell Transplantation (38 papers), Chronic Myeloid Leukemia Treatments (16 papers), Antifungal resistance and susceptibility (10 papers), Neutropenia and Cancer Infections (7 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Hematology (10.9k citations), Public Health, Environmental and Occupational Health (6.3k citations), Oncology (1.8k citations), Molecular Biology (3k citations) and Genetics (288 citations). Xavier Thomas has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Hervé Dombret, Emmanuel Raffoux, Françoise Huguet, Denis M. Fiere, Claude Preudhomme, Véronique Lhéritier, Pierre Fenaux, Mauricette Michallet, Eric Archimbaud and Nicolas Boissel. Their work appears in journals such as Blood, Leukemia, Journal of Clinical Oncology, Leukemia Research and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.